KKR & Co. Inc.
KKR & Co. Inc. (KKR) Financial Performance & Income Statement Overview
Analyze KKR & Co. Inc. (KKR) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
KKR & Co. Inc. (KKR) Income Statement & Financial Overview
Analyze KKR & Co. Inc.’s KKR earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $3.05B | $3.20B | $4.73B | $4.11B |
| Cost of Revenue | $3.14B | $2.25B | $3.85B | $3.13B |
| Gross Profit | -$84.67M | $948.76M | $885.64M | $980.89M |
| Gross Profit Ratio | -$0.03 | $0.30 | $0.19 | $0.24 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $622.02M | $656.02M | $821.60M | $753.45M |
| Operating Expenses | $622.02M | $656.02M | $821.60M | $753.45M |
| Total Costs & Expenses | $3.76B | $2.91B | $4.67B | $3.88B |
| Interest Income | $785.86M | $809.64M | $854.93M | $903.86M |
| Interest Expense | $724.07M | $847.83M | $800.45M | $849.003M |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $0.00 |
| EBITDA | $1.50B | $2.49B | $2.45B | $2.06B |
| EBITDA Ratio | $0.49 | $0.78 | $0.52 | $0.50 |
| Operating Income | -$706.69M | $292.74M | $64.04M | $227.44M |
| Operating Income Ratio | -$0.23 | $0.09 | $0.01 | $0.06 |
| Other Income/Expenses (Net) | $1.48B | $1.35B | $1.58B | $982.76M |
| Income Before Tax | $771.07M | $1.64B | $1.64B | $1.21B |
| Income Before Tax Ratio | $0.25 | $0.51 | $0.35 | $0.29 |
| Income Tax Expense | $86.57M | $258.33M | $209.90M | $216.97M |
| Net Income | -$185.92M | $1.13B | $600.55M | $667.93M |
| Net Income Ratio | -$0.06 | $0.35 | $0.13 | $0.16 |
| EPS | -$0.22 | $1.27 | $0.68 | $0.75 |
| Diluted EPS | -$0.22 | $1.18 | $0.64 | $0.72 |
| Weighted Avg Shares Outstanding | $888.25M | $888.22M | $887.44M | $887.39M |
| Weighted Avg Shares Outstanding (Diluted) | $888.25M | $956.27M | $941.97M | $932.05M |
Financial performance has remained strong, with revenue growing from $4.11B in Q2 2024 to $3.05B in Q1 2025. Gross profit continued to perform well, with margins at -3% in the latest quarter. Operating income reached -$706.69M in Q1 2025, holding a steady -23% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $1.50B. Net income dropped to -$185.92M, keeping EPS at -$0.22. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan